Results 1 - 10 of 2,285

and Selected Gram-Negative Organisms

by Michael T. Sweeney, Gary E. Zurenko, Staphylococci Enterococci Pneumococci, Michael T. Sweeney, Gary E. Zurenko , 2003
"... This article cites 20 articles, 14 of which can be accessed free ..."
Abstract - Add to MetaCart
This article cites 20 articles, 14 of which can be accessed free

Nonfermentative Gram-Negative Organisms �

by J. W. Snyder, G. K. Munier, C. L. Johnson, J. W. Snyder, G. K. Munier, C. L. Johnson , 2008
"... This article cites 16 articles, 12 of which can be accessed free ..."
Abstract - Add to MetaCart
This article cites 16 articles, 12 of which can be accessed free

and Gram-Negative Organisms as Demonstrated by Studies of

by F J Boswell, J M Andrews, R Wise, F. J. Boswell, J. M. Andrews, R. Wise , 1996
"... and postantibiotic effect. kineticsas demonstrated by studies of time-kill organismson gram-positive and gram-negative Pharmacodynamic properties of BAY 12-8039 ..."
Abstract - Add to MetaCart
and postantibiotic effect. kineticsas demonstrated by studies of time-kill organismson gram-positive and gram-negative Pharmacodynamic properties of BAY 12-8039

Gram-negative organisms including Enterobacter

by Krasimir Vasilev, Galina Reshedko, Remus Orasan, Miguel Sanchez, Juri Teras, Tim Babinchak, Gary Dukart, Angel Cooper, Nathalie Dartois, Hassan G, Russ Orrico
"... A Phase 3, open-label, non-comparative study of tigecycline in the ..."
Abstract - Add to MetaCart
A Phase 3, open-label, non-comparative study of tigecycline in the

Lyamuya, “Prevalence of multiresistant gram-negative organisms in a tertiary hospital

by Stephen E Mshana, Erasmus Kamugisha, Mariam Mirambo, Trinad Chakraborty, Eligius F Lyamuya, Mariam Mirambo, Trinad Chakraborty, Eligius F Lyamuya - in Mwanza, Tanzania,” BMC Research Notes
"... Background: Antimicrobial resistance is fast becoming a global concern with rapid increases in multidrug-resistant Gram negative organisms. The prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates increases the burden on implementing infectious disease management in low ..."
Abstract - Cited by 3 (1 self) - Add to MetaCart
socio-economic regions. As incidence can vary widely between regions, this study was done to determine resistance patterns of Gram-negative organisms at Bugando Medical Center, a tertiary hospital in Mwanza, Tanzania. Methods: A total of 800 clinical samples (urine, wound swab, pus, blood, aspirate

Monoclonal Antibody HA-1A with Lipopolysaccharides from Rough and Smooth Gram-Negative Organisms

by P E Daddona, M A Mascelli, B Frederick, T Ely, D S Neblock, D J Shealy, Mary Ann Mascelli, Bart Frederick, Therese Ely, T Donald S. Neblock, David J. Shealy, Koon Yan Pak, Peter, E. Daddona , 1992
"... smooth gram-negative organisms. with lipopolysaccharides from rough and HA-1Aimmunoglobulin M monoclonal antibody Reactivity of the human antiendotoxin ..."
Abstract - Add to MetaCart
smooth gram-negative organisms. with lipopolysaccharides from rough and HA-1Aimmunoglobulin M monoclonal antibody Reactivity of the human antiendotoxin

clinical consultations Gram-negative organisms Is double coverage of gram-negative organisms necessary?

by Sarah J Johnson , Erika J Ernst , Kevin G Moores
"... ..."
Abstract - Add to MetaCart
Abstract not found

Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics

by unknown authors
"... Objectives: A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem and g ..."
Abstract - Add to MetaCart
Objectives: A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem

Ciprofloxacin use and susceptibility of Gram-negative organisms to quinolone and non-quinolone antibiotics

by unknown authors
"... Objectives: A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem and g ..."
Abstract - Add to MetaCart
Objectives: A Trust strategy to reduce ciprofloxacin use was implemented at a University hospital. This study aimed to investigate whether the susceptibility of Gram-negative organisms (GNO) to alternative antimicrobials (co-amoxiclav, doxycycline, aztreonam, piperacillin/tazobactam, meropenem

Recent taxonomic changes for anaerobic Gram-positive and selected Gram-negative organisms

by Paula Summanen, Veterans Administration, Wadsworth Medical - Clin. Infect. Dis , 1993
"... The strains formerly classified as Streptococcus anginosus or "Streptococcus milleri " have now been recognized as three distinct species, Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius. Streptococcus morbillorum has been transferred into the genus Ge-me ..."
Abstract - Cited by 1 (0 self) - Add to MetaCart
in periodontal pockets. Bilophila is a new genus of gram-negative bacilli. Wolinella recta and Wolinella curva are now included in the genus Campy-lobacter. The taxonomic position of Mobiluncus, currently assigned to the family Bacteroidaceae, remains uncertain. Traditionally, the grouping of anaerobic organisms
Results 1 - 10 of 2,285